For his very first marathon, Daniel will be running in memory of his mother-in-law, Makiko Moni who passed away from esophageal cancer. Daniel has created an online fundraising page to help raise funding for esophageal cancer research. With less than one month until race day, we hope you will take a moment to read Daniel’s story, share his campaign and consider supporting his efforts through a donation. On behalf of The Salgi Esophageal Cancer Research Foundation, we would like to thank Daniel for bringing awareness to esophageal cancer and raising much needed funds for awareness and research!
Daniel’s fundraiser: Running for Maki
As many of you know, we suffered a great tragedy earlier this year with the passing of my mother-in-law, Makiko Monji. She was so kind, generous, stylish, talented, loving, and full of life – Maki was truly a special person who was beautiful in every way. We miss her dearly. Sadly, she was afflicted with a terrible disease, esophageal cancer, that ended her life far too quickly.
On November 3, 2019, I will be running the New York City Marathon, my first marathon. I have been training hard and I am proudly dedicating my run to Maki’s memory and life. She was always so supportive of everyone and inspiring to others – I know she will be with me as I run.
I have decided to use this opportunity to raise money for the Salgi Esophageal Cancer Research Foundation in Maki’s honor. Salgi funds research into methods for early detection and treatment of esophageal cancer, which, unfortunately, is a devastating disease that is often caught too late to be effectively treated. Esophageal cancer is also one of the fasting growing cancers in the world (600% increase in diagnoses over the last 30 years), but is relatively unknown and is lacking in research funding and awareness among the general public. Please visit salgi.org for more information regarding esophageal cancer awareness, early detection, and research.
Your support would be greatly appreciated – every contribution will help carry me to the finish line and will go towards the fight against esophageal cancer!
Thank you!
PS: If you want to track me as I run, my bib number is 32610 (use the New York Road Runners app). I hope to see you out there on race day!
Learn the Facts:
Esophageal cancer is considered one of the fastest growing and deadliest cancer in the United States and western world. Esophageal cancer has increased over 700% in the past three decades and has an overall 5 year survival rate of only 19.2%. There are no routine or standard screenings to improve early detection of esophageal cancer and symptoms often arise late, once the cancer is considered advanced or “distant” (spread to lymph nodes and other organs.) Stage IV esophageal cancer has a survival rate of only 4.8%.
Despite these facts, esophageal cancer research is extremely underfunded. In 2015, The Salgi Esophageal Cancer Research Foundation awarded esophageal cancer research funding for the very first time. Then, in November, 2018, we have once again awarded funding for esophageal cancer research. Both grants were given in honor of all the men and women affected by esophageal cancer.
This article was posted onMDLinx.com‘s to view the original article, click here.
“In a nationwide cohort study, researchers investigated if survival in esophageal cancer (esophageal adenocarcinoma) (EAC) is influenced by gastroesophageal reflux disease (GERD) or endoscopy practice. Participants were all Swedish residents (n = 6,600) (79.3% males, median age 70 years) who received a diagnosis of esophageal cancer (EAC) in 1997-2013 and were followed till 2018. History of GERD and endoscopies before EAC were the exposures. EAC-specific 5-year mortality was assessed as the main outcome. Findings revealed a possible association of GERD with a better prognosis in the event of EAC. However, the limited influence of the use of endoscopy screening on survival was reported unless performed very frequently.”
-As one of the deadliest cancers, esophageal cancer has an overall 5 year survival rate of only 19.2%.
-There are no routine or standard screenings to improve early detection of esophageal cancer.
-Symptoms often arise late, once the cancer is considered advanced or “distant” (spread to lymph nodes and other organs.)
-Stage IV esophageal cancer has a survival rate of only 4.8%.
-Despite these facts, esophageal cancer research is extremely underfunded.
To make a tax-deductible donation to The Salgi Esophageal Cancer Research Foundation, please visit: salgi.org/donate
Editor Note:
Content may be edited.
Disclaimer
This post contains information from an article regarding recently published research and reflects the content of that research. It does not necessarily reflect the views or opinions of The Salgi Esophageal Cancer Research Foundation who cannot be held responsible for the accuracy of the data.
The Salgi Esophageal Cancer Research Foundation is a 501 (c) (3) non profit organization as recognized by the Internal Revenue Service.
Content found on Salgi.org is for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
When we first spoke with Dara about hosting an event in New York, we were excited to work together on hosting an event yet heartbroken to hear that her father’s battle with esophageal cancer was similar to our loved ones battle. It is our hope that this event will bring much attention to the dire need for awareness, prevention, improved and routine screenings, innovative treatments and funding for esophageal cancer research.
The Salgi Esophageal Cancer Research Foundation is honored to present to you our 1st Annual Esophageal Cancer Awareness Run/Walk event to Brooklyn, New York. The event will take place on Saturday, September 14, 2019 at Marine Park. The event is being hosted by our lead event coordinator and New York chapter representative, Dara M. and elitefeats. Guests may either walk or run and can sign up online by Friday, September 13, 2019 at 5 PM EST. Volunteers are also welcome. Click here for more information and to sign up!
Here is Dara’s story:
Our Battle Against Esophageal Cancer: Joe’s Journey
“For many people, indigestion, acid reflux, GERD and heartburn are ailments that can be treated with common over-the-counter medications. More severe cases of gastroesophageal reflux might require stronger drugs that can be prescribed by a doctor for as long as symptoms persist.
This was how my father, Joseph M., began his battle with esophageal cancer.
Even though my dad was a smoker and drank when he was younger, there were no signs or symptoms of any complications until ten years after he’d been working at a print shop in Queens, New York. Exposed to paint thinners, chemicals and other toxic fumes that emitted from heavy machinery at work, he came home every day wreaking of industrial substances.
His heartburn began around 2005 and was a mild nuisance, which he solved by devouring dozens of boxes of Tums every week. When he went to the doctor a couple of years later to complain of more painful indigestion, as his diet began to change because he couldn’t eat spicy foods or enjoy pasta sauce the way he used to, they prescribed pills like Nexium to quell the stomach acid and discomfort.
We thought his chronic heartburn would simply need continuous medication until the afternoon of Fourth of July in 2008, when we were in the city and on our way to see the Macy’s Fireworks display – a father/daughter tradition we had for several years. We went to a delicious chicken place that had some awesome cornbread! It seemed to happen so abruptly – as my father was in the middle of eating, food suddenly became lodged in his esophagus. We didn’t know it was even possible for food to get “stuck” in this digestive tract, but he couldn’t get water or any food to flow down to his stomach.
Suffice to say, our father-daughter day was cut short as we left the city and he tried to push the food down with more water, which only worked for so long. Eventually, the food that was lodged in his esophagus slowly dissolved and the scare of seeing my father not being able to eat was only part of the problem.
Another trip to the doctor – and explaining to a gastroenterologist what happened – seemed to rip open another bag of unwanted surprises. The blur began as my father was given appointments with specialists months after that Fourth of July incident. X-rays showed that there was some type of obstruction and tissue inflammation in his esophagus. By September or so, doctors finally ordered my dad to have an endoscopy so they could biopsy the cells.
There were all sorts of words and medical terms thrown around as my dad was scrutinizing and amending his diet – Barrett’s esophagus, esophagectomy…but I will never forget the day we met with a surgeon who followed up on the gastroenterologists findings. The day they told us my father had esophageal cancer. My reaction to this years later remains a numbing haze, even though I recall wondering what this disease was! I knew cancerous cells could develop anywhere in the body, but this heartbreaking news led to a slew of nightmares that me, my dad and I’m sure thousands of other families have had to experience after initial diagnosis.
At first, doctors recommended chemotherapy and radiation to shrink the cells and advised us that surgery was a last resort to remove the cancer and any infected lymph nodes. Before my dad’s chemo and radiation even began, his oncologist recommended my dad have a port-a-cath – or chemo port – placed in his chest to administer medications and blood tests. I will never forget how my dad went in for what was supposed to be a simple outpatient procedure the week of Thanksgiving for the chemo port but instead, as the doctors were inserting it into his body, the tube punctured his lungs. Not only did he miss Thanksgiving of 2008 because his left lung had collapsed, his chemo/radiation treatments were set back by a few weeks as he recovered from the painful blow.
As many cancer patients experience, my dad endured rough chemotherapy treatments and his appetite – along with the cancer – was very slowly shrinking. He was ordered to have endoscopies every few months, which became a scary routine to prep for and recover from. We were told his cancer was in Stage 3 and that there was a chance he’d fight it – even after it seemed to go into remission for a couple of months in summer of 2009.
The hardest part of seeing a loved one suffer as they battle esophageal cancer is knowing that they can’t eat normally, even after rounds of chemo and radiation. Their diets completely change – if they can manage to eat at all – and losing weight becomes a major concern, as they’re not able to take in the nutrients the body needs to function. Drinking nutrition shakes and supplements was also sickening at some point.
Sadly, in early 2010, my father found that the cancer cells had returned. We also returned to the idea of surgery. This would ultimately involve, as the oncologist told us in detail, having part of the esophagus removed and surgeons pulling up and rebuilding a portion of the stomach. This invasive procedure would be two-pronged. Yes, it would essentially remove the central portion of the cancer and some lymph nodes, but there was also the risk of the cancer spreading post-surgery.
One of the worst aspects of having an esophagectomy, as I’ve heard from others with the same experiences, is not being able to eat for weeks or months after the surgery. If my dad opted for the surgery, he would have had to use a feeding tube for a long time and the recovery from the procedure would have possibly been ten times worse than continuing short-term treatment.
My father looked to me for direction – continue with chemo or go under the knife? I couldn’t honestly bear to see my dad having any more invasive procedures and by spring 2010, he painstakingly asked me to enroll him in a hospice program. What drove the knife through my heart was knowing he didn’t want to die and he didn’t want to become a statistic of a cancer that neither of us had ever heard of until 2 years before when he was diagnosed.
It was during this time, as my dad was provided with heavy medications at home, that I began looking up esophageal cancer on social media. I started reading other families’ experiences and diagnosis. It was truly unbelievable to me that all of us experienced this same journey – many only lasting 2-3 years before the battle became too much to handle nutritionally, mentally, physically, emotionally and medically. A lucky handful were able to say they were survivors after surgery.
Every story I’d read, and still read today, is filled with shock at how insurance companies refuse to cover some of the tests for esophageal cancer in its early stages. And then I question, can this cancer be caught early enough somehow to prevent or slow down cells from becoming cancerous? Are doctors ignoring the serious warning signs and pushing pills like they did to my dad before that doomed day which changed our lives?
My family got the call on October 16, 2010, a little over 12 hours after we had to place my father in a facility for hospice. I was only thankful that he wasn’t suffering anymore and he wasn’t fighting to stay alive.
Over the past few years, as I looked back on my father’s battle, I became a runner and subsequently found that it was rewarding to participate in 5K races for a good cause. I’d run races bringing awareness to ovarian cancer, another disease for which there is no screening, as well as testicular cancer.
However, after much research, I’d discovered there was little attention brought to any events focusing on esophageal cancer in New York City. With a growing number of New Yorkers being exposed to toxic fumes and work conditions, no matter how healthy their lifestyles are, I was surprised to find that no one was sponsoring an event to bring this complex cancer to the forefront of the public.
As I continued to read stories about those whose lives were taken by esophageal cancer, I noticed the trends in diagnosis, treatment and lack of awareness/education. Finally deciding that I wanted to help spread the word to more people in my city and give others tools to recognize their own health conditions, I scoped out an organization that could assist with my new mission.
I came across the Salgi Esophageal Cancer Research Foundation on social media and started 2019 with a simple phone conversation with the organization’s Executive Director, Christina. We also shared the same experience, as she explained the passing of her grandfather came after a similar struggle I’d gone through with my father.
With no races/walks, fundraisers or awareness events in my city aimed at esophageal, I proposed we host an event in Brooklyn to bring light to the lesser-known cancer. After a little more research, I decided it would be a great idea to find a race organization to provide the provisions for the event. Working out the details with elitefeats, a race organization I’m quite familiar with, helped bring the mission to life.
Fundraising for esophageal cancer awareness is more than just about coming to our event in September and running for a cure. Through sponsorship and dedication to spreading the word, my ultimate goal is to provide others with tools to make themselves and their loved ones more vigilant when it comes to their digestive health.
The “Esophageal Cancer Awareness Run/Walk NYC” will serve as a resourceful awakening for many New Yorkers who aren’t familiar with this disease. I’m also hoping it will somehow reach medical experts and specialists who often brush off those signs or are hesitant to diagnose something that can become more serious.
Stories like my dads are becoming more and more common and it doesn’t get any easier to recall the way his life ended. My passion now is to keep his memory alive by hosting this fundraiser that will hopefully help others write a different story in years to come.”
The Salgi Esophageal Cancer Research Foundation is a 501 (c) (3) non profit organization as recognized by the Internal Revenue Service.
Content found on Salgi.org is for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
“The American Society for Gastrointestinal Endoscopy (ASGE) has released its updated “ASGE guideline on screening and surveillance of Barrett’s esophagus,” published in the September issue of GIE: Gastrointestinal Endoscopy.
The guideline aims to help clinicians understand the published literature and quality of available data on screening and surveillance in patients with Barrett’s esophagus; a precancerous condition for esophageal cancer (adenocarcinoma.) This document addresses several key clinical issues in this field, including the role and impact of screening and surveillance of Barrett’s esophagus. As with other types of cancer, identifying this precancerous condition and early changes of cancer provides the best chance of successful treatment and, ultimately, improves patient outcomes.
Several endoscopic procedures and related technologies are used to screen and monitor patients with known or suspected Barrett’s esophagus. If changes are found in the cells lining the esophagus, various endoscopic treatment approaches are available.
This guideline addresses the utility of advanced imaging and sampling modalities used during screening and surveillance endoscopic procedures and includes chromoendoscopy, confocal laser endomicroscopy, endoscopic ultrasound, wide-area transepithelial sampling (WATS) and others. Table 4 contains a summary of the recommendations.
The document complies with the standards of guideline development set forth by the Institute of Medicine for the creation of trustworthy guidelines and provides recommendations based on the GRADE framework.
“We are hopeful that this current information will help guide clinicians in using the growing array of tools and technologies available to us to diagnose and manage Barrett’s esophagus, which, in turn, has the potential to significantly impact patient outcomes,” said Sachin Wani, MD, FASGE, Chair of the ASGE Standards of Practice Committee.”
Barrett’s esophagus is one possible risk factor associated with esophageal cancer, which is one of the fastest growing and deadliest cancers in the United States. There are no routine screenings to detect esophageal cancer in earlier stages and symptoms (such as difficulty swallowing, choking sensation, etc…) often occur once the cancer spreads and becomes more difficult (if not impossible) to treat.”
Learn the facts about esophageal cancer
-Esophageal cancer has increased over 700% and is considered one of the fastest growing cancer in the US.*
Qumseya, B. et al. (2019) ASGE guideline on screening and surveillance of Barrett’s esophagus. Gastrointestinal Endoscopy. doi.org/10.1016/j.gie.2019.05.012.
Editor Note:
Content may be edited.
Disclaimer
This post contains information from an article regarding recently published research and reflects the content of that research. It does not necessarily reflect the views or opinions of The Salgi Esophageal Cancer Research Foundation who cannot be held responsible for the accuracy of the data.
To read more esophageal cancer news, please visit: SALGI.org/news
The Salgi Esophageal Cancer Research Foundation is a 501 (c) (3) non profit organization as recognized by the Internal Revenue Service.
Content found on Salgi.org is for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
This article was posted on to view the original article, please click here.
“Researchers at Trinity College Dublin have identified, for the first time in esophageal cancer, the cancer killing capability of a lesser-known type of immune cell, presenting a new potential therapeutic target. Their research has been published today in the international journal Frontiers in Immunology here.
Esophageal cancer is a very aggressive type of cancer with poor prognosis, and the 5-year survival rate is typically less than 15%. Linked with obesity, esophageal cancer is one of the fastest growing cancers in the Western world and incidence is due to double in Ireland within the next few decades. Current treatment strategies work well but only for a minority (approx. 25%) of patients so new treatment options are urgently needed.
New treatment strategies targeting the immune system have had revolutionary effects in other cancer types, but the latest clinical trials show that, disappointingly, immunotherapy offers no real benefit for the majority of patients with esophageal cancer.”
Esophageal cancer is one of the fastest growing and deadliest cancers in the United States. There are no routine screenings to detect esophageal cancer in earlier stages and symptoms (such as difficulty swallowing, choking sensation, etc…) often occur once the cancer spreads and becomes more difficult (if not impossible) to treat.
Learn the facts about esophageal cancer
-Esophageal cancer has increased over 700% and is considered one of the fastest growing cancer in the US.*
-As one of the deadliest cancers, esophageal cancer has an overall 5 year survival rate of only 19.2%.
-There are no routine or standard screenings to improve early detection of esophageal cancer.
-Symptoms often arise late, once the cancer is considered advanced or “distant” (spread to lymph nodes and other organs.)
-Stage IV esophageal cancer has a survival rate of only 4.8%.
-Despite these facts, esophageal cancer research is extremely underfunded.
To make a tax-deductible donation to The Salgi Esophageal Cancer Research Foundation, please visit: salgi.org/donate
The Salgi Esophageal Cancer Research Foundation is a 501 (c) (3) non profit organization as recognized by the Internal Revenue Service.
Content found on Salgi.org is for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
What if a “cancer breathalyzer” could detect esophageal cancer so early that many patients could be cured without surgery, chemotherapy or radiation? Virginia Mason surgeon Donald Low, MD, FACS, intends to find out, by developing a breath test that could transform diagnosis for the deadly disease.
“Esophageal cancers don’t typically show symptoms until they’re very advanced, which is why only 20 to 30 percent of patients live for five years after diagnosis,” Dr. Low says. “If a breath test could detect esophageal cancer before it spreads, we could cure many patients with an endoscopic procedure.”
The Salgi Foundation
The research is fueled by the Salgi Esophageal Cancer Research Foundation, which pools donations from individuals to fight esophageal cancer.
The Salgi Esophageal Cancer Research Foundation is a 501 (c) (3) non profit organization as recognized by the Internal Revenue Service.
Content found on Salgi.org is for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
As we near the end of April, recognized as Esophageal Cancer Awareness Month, I felt it important to reach out to all of our wonderful donors and supporters. Our support has come from people who have been adversely affected by this horrific disease: the family members and friends of those diagnosed with esophageal cancer, the men and women who continue to battle this cancer day in and day out, our survivors and those who we will hold close in our memories and in our hearts forever. We’ve shared our sorrows and joys with so many people throughout the years because we, too, have personal experience with esophageal cancer.
Since this charity was founded a mere nine years ago, we have already funded research twice! This is an accomplishment that would not have been brought to fruition without our supporters. We do not receive any corporate or government grants monies to fund the charity or the core mission; we simply rely on the generosity of our donors.
We, too, are people who have been directly affected by esophageal cancer and we have felt the pain, just as so many of our supporters have. We recognize the extreme need for raising awareness of the risk factors and symptoms associated with this cancer, as so many people are still not aware of them or esophageal cancer at all. We advocate for the early detection of this disease, due to the fact that by the time symptoms are noticed, the cancer has already progressed. We actively pursue funding for research so that we can change esophageal cancer’s destructive course. We do all this, always, in hopes of a cure™.
So, during April, the month dedicated to Esophageal Cancer Awareness, I wish to thank everyone who has supported and will continue to support The Salgi Esophageal Cancer Research Foundation’s efforts because it is together that we will make a difference. Together, we will end esophageal cancer.
Below is a story from a wife of a man who was diagnosed with esophageal cancer. We are very thankful to this couple for sharing their personal experiences with us in order to bring awareness to this devastating cancer. As his wife said, “I want to bring hope to people facing this horrible disease. [My husband} is a testament to fighting and winning!”
Survivor Story: Borden. Story by wife, Mary A.
My husband was diagnosed on March 3, 2009 with stage 3 Esophageal cancer. He fought it with chemo and radiation first then after 2 months if intensive treatments had the 9.5 hr surgery to remove the cancer. He had to learn how to swallow again and ate through a feeding tube for 7 months. It was such a scary time for us.
Jump ahead to ten years later, he’s doing great!!! He survived with lots of care and prayer. My prayers were answered and I hope his story will help others know, yes you can beat this awful disease!
Awareness, Early Detection and Research
Too often, esophageal cancer is ignored and disregarded. There is a tremendous need to bring not only awareness but tools and resources to encourage early detection and advocacy and actual funding for esophageal cancer research.
The personal stories we share on our website do just that. They are each equally important and deserve to be published. Please do not reproduce any of these stories without our permission. You may contact us with any questions or comments.
Do you have an experience with esophageal cancer that you would like to share either publicly or privately? To learn more, please visit: Share Your Story.
The Salgi Esophageal Cancer Research Foundation has issued funding for esophageal cancer research in November, 2018; the second time in just seven years since the charity was founded.
The Foundation awarded principal investigator, Dr. Donald Low and Virginia Mason Medical Center, grant funding. Dr. George Hanna of St Mary’s Hospital (Imperial College London) is co-investigator. The research is currently underway.
In 2011, The Salgi Esophageal Cancer Research Foundation was established to raise awareness, encourage early detection and to fund research of esophageal cancer. Since 2011, the foundation has both raised awareness and encouraged the importance of earliest possible detection throughout New England, across the United States and internationally. The Salgi Esophageal Cancer Research Foundation first funded esophageal cancer research in July, 2015.
“The Salgi Esophageal Cancer Research Foundation is excited to be a part of Dr. Low’s, Professor Hanna’s and Virginia Mason’s research efforts in honor of all the brave men and women who have been affected by esophageal cancer and to hopefully reduce incidence and improve outcomes for individuals in the future,” President of the foundation, stated.
The research intends to establish a non-invasive test for the detection of esophageal cancer that is based upon the unique signature of volatile organic compounds (VOCs) within exhaled breath and to analyze exhaled VOCs in response to therapeutic intervention in patients.
Learn the Facts About Esophageal Cancer
One of the primary risk factors associated with esophageal cancer is Gastroesophageal Reflux Disease, also known as GERD or acid reflux disease, of which the most common symptom is chronic heartburn. Other risk factors include obesity, heavy drinking, poor nutrition and smoking and/or use of tobacco products.
With over a 733% increase in the past four decades, esophageal cancer is among the fastest growing and deadliest cancers in the United States and the western world.1
There are no current standard or routine screenings to detect esophageal cancer in its earlier stages. Current guidelines recommend referral for endoscopy “only in the setting of ‘red flag’ symptoms that are frequently associated with inoperable disease,” Dr. Low stated.
These ‘red flag’ symptoms, such as difficulty swallowing, typically appear once the cancer has become advanced. This, in addition with other factors mentioned, leads to the current overall five-year survival rate of only 19.2%.2 Despite its rapid increase and poor prognosis, esophageal cancer receives very little awareness and research funding.
The Salgi Foundation: Past Esophageal Cancer Research Funding
In July, 2015, the Salgi Esophageal Cancer Research Foundation issued esophageal cancer research funding to Program Director Dr. Carlos Minacapelli and Rutgers Robert Wood Johnston Medical School. That research was presented as a poster presentation during Digestive Disease Week in May, 2017.
Thank you!
The Salgi Esophageal Cancer Research Foundation would like to thank all our supporters and donors who believe in this mission and who make these accomplishments possible. However, this is just the beginning. The Salgi Esophageal Cancer Research Foundation continuously receives many requests for esophageal cancer research. We need to continue our efforts to fundraise so that we may continue to fulfill this mission to raise awareness, encourage early detection and fund research.
To make a tax-deductible donation to The Salgi Esophageal Cancer Research Foundation, please visit: SALGI.org/donate.
The Salgi Esophageal Cancer Research Foundation is a 501 (c) (3) non profit organization as recognized by the Internal Revenue Service.
Content found on Salgi.org is for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Make a charitable gift to The Salgi Esophageal Cancer Research Foundation to support esophageal cancer awareness, early detection and research. Donate Now! All donations are 100% tax deductible.
PLUS!
On November, 27th, 2018, Facebook will match a total of up to $7 million in donations made on Facebook to eligible US-based 501(c)(3) nonprofits like The Salgi Esophageal Cancer Research Foundation!
Giving Tuesday opens the giving season and with your help, we will raise funds to raise awareness, encourage early detection and fund research of esophageal cancer…in hopes of a cure.™
Giving Tuesday helps to unite us in the spirit of giving and to bring a spotlight to esophageal cancer, a cause that needs desperate attention. Let’s make this Giving Tuesday a great success! Please donate today! Thank you in advance for helping to make a difference today and every day.
The Salgi Esophageal Cancer Research Foundation is a registered nonprofit as recognized by the IRS. EIN: 453633809
The Salgi Esophageal Cancer Research Foundation is a 501 (c) (3) non profit organization as recognized by the Internal Revenue Service.
Content found on Salgi.org is for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Posted by salgiblogs 
My family got the call on October 16, 2010, a little over 12 hours after we had to place my father in a facility for hospice. I was only thankful that he wasn’t suffering anymore and he wasn’t fighting to stay alive.
The Salgi Esophageal Cancer Research Foundation 